Chemotherapy, endocrine therapy, and targeted therapy play a crucial role in the treatment of breast cancer, and the choice of appropriate treatment strategies depends on the expression level of molecular markers for estrogen receptors (ER) or progesterone receptors (PR) and human epidermal growth factor 2 (HER2) [3]. Here, ERBB2 is linked to breast carcinoma.